An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors

Genes and Development

Volumn 16, Issue 1, 2002, Pages 127-137

  Seidel, J J ^a   Graves, B J ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Docking site; Ets l; MAPK; Phosphorylation

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR ETS 2;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CATALYSIS; DNA BINDING; DROSOPHILA; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME SPECIFICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; THERMODYNAMICS; TRANSACTIVATION;

3T3 CELLS; ANIMALS; BINDING SITES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; PHOSPHORYLATION; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0036142763     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.950902     Document Type: Article

References (52)

1. Mae mediates MAP kinase phosphorylation of Ets transcription factors in Drosophila
2. Mouse models in the study of the Ets family of transcription factors
3. The ETS domain protein pointed-P2 is a target of MAP kinase in the sevenless signal transduction pathway
4. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation
5. Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9
6. Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies
7. Mammalian MAP kinase signalling cascades
8. Phosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition
9. Docking sites on substrate proteins direct extracellular signal-regulated kinase to phosphorylate specific residues
10. Solution structure of ERK2 binding domain of MAPK phosphatase MKP-3: Structural insights into MKP-3 activation by ERK2
11. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein
12. Neuregulin-l-stimulated phosphorylation of GABP in skeletal muscle cells
13. Selective targeting of MAPKs to the ETS domain transcription factor SAP-1
14. Calculation of protein extinction coefficients from amino acid sequence data
15. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
16. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia
17. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia
18. Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases
19. Specificity within the ets family of transcription factors
20. Genetic analysis of ETS genes in C. elegans
21. Protein modification: Docking sites for kinases
22. Sequence and functional properties of Ets genes in the model organism Drosophila
23. A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype
24. Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase
25. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFRβ oncoprotein
26. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions
27. Reconstitution of mitogen-activated protein kinase phosphorylation cascades in bacteria. Efficient synthesis of active protein kinases
28. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation
29. Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression
30. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
31. Transformation of mammalian cells by constitutively active MAP kinase kinase
32. Eukaryotic expression vectors for the analysis of mutant proteins
33. Regulation of lymphoid-specific immunoglobulin μ heavy chain gene enhancer by ETS-domain proteins
34. The activities of two Ets-related transcription factors required for Drosophila eye development are modulated by the Ras/MAPK pathway
35. Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1/ETV6
36. Mutation of position 52 in ERK2 creates a nonproductive binding mode for adenosine 5′-triphosphate
37. Two independent activation domains in c-Ets-1 and c-Ets-2 located in non-conserved sequences of the ets gene family
38. The ETS-domain transcription factor family
39. Docking domains and substrate-specificity determination for MAP kinases
40. Structure of the Ets-1 pointed domain and mitogen-activated protein kinase phosphorylation site
41. ets-2 is a target for an Akt (protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice
42. The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization
43. A conserved docking motif in MAP kinases common to substrates, activators and regulators
44. Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions
45. Purification of a model substrate for transcription factor phosphorylation by erk2
46. TEL contacts multiple corepressors and specifically associates with histone deacetylase-3
47. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor
48. Hydrophobic as well as charged residues in both MEK1 and ERK2 are important for their proper docking
49. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets-1 and c-Ets-2
50. Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1
51. The Elk-1 ETS-domain transcription factor contains a mitogen-activated protein kinase targeting motif
52. Signal transduction and the Ets family of transcription factors